₹ 810.00
11.10 (1.39%)
NSE
R
Remus Pharmaceuticals
₹ 810.00
NSE
Remus Pharmaceuticals EPS Summary (consolidated)
For the FY2026 the EPS of Remus Pharmaceuticals stands at ₹39.19. This is a 20.18% growth compared with FY2025.
Remus Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

